NLNK Share Price

Open 10.51 Change Price %
High 11.19 1 Day 0.18 1.71
Low 10.51 1 Week -1.34 -11.12
Close 10.71 1 Month 0.12 1.13
Volume 235806 1 Year -25.17 -70.15
52 Week High 37.65
52 Week Low 0.00
NLNK Important Levels
Resistance 2 11.34
Resistance 1 11.08
Pivot 10.80
Support 1 10.34
Support 2 10.08
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.70 0.20%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
RITT 0.06 -45.45%
More..

NewLink Genetics Corporation (NASDAQ: NLNK)

NLNK Technical Analysis 5
As on 2nd Dec 2016 NLNK Share Price closed @ 10.71 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 15.33 & Strong Sell for SHORT-TERM with Stoploss of 13.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
NLNK Target for December
1st Target up-side 13.13
2nd Target up-side 14.57
3rd Target up-side 16.01
1st Target down-side 9.03
2nd Target down-side 7.59
3rd Target down-side 6.15
NLNK Other Details
Segment EQ
Market Capital 281938752.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.newlinkgenetics.com
NLNK Address
NLNK
2503 South Loop Drive
Ames, IA 50010
United States
Phone: 515-296-5555
Fax: 515-296-3520
Interactive Technical Analysis Chart NewLink Genetics Corporation ( NLNK NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on NewLink Genetics Corporation
NLNK Business Profile
NewLink Genetics Corporation operates as a biopharmaceutical company. The Company, based in the United States, is focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians. Its HyperAcute cancer immunotherapies aim to treat non-small cell lung cancer, pancreatic cancer, melanoma, prostate cancer, and breast cancer.